BML-281   Click here for help

GtoPdb Ligand ID: 9664

Synonyms: compound 3 [PMID: 18642892]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: BML-281 is an experimental selective HDAC6/3 inhibitor [2], that has demonstrated anti-inflammatory activity in a murine model of colonic inflammation [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 4
Rotatable bonds 15
Topological polar surface area 142.79
Molecular weight 446.22
XLogP 3.28
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
Isomeric SMILES ONC(=O)CCCCCCNC(=O)c1noc(c1)c1ccc(cc1)NC(=O)OC(C)(C)C
InChI InChI=1S/C22H30N4O6/c1-22(2,3)31-21(29)24-16-11-9-15(10-12-16)18-14-17(26-32-18)20(28)23-13-7-5-4-6-8-19(27)25-30/h9-12,14,30H,4-8,13H2,1-3H3,(H,23,28)(H,24,29)(H,25,27)
InChI Key WWGBHDIHIVGYLZ-UHFFFAOYSA-N
Bioactivity Comments
BML-821 exhibits potent antiproliferative activity against pancreatic cancer cell lines in vitro [2].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
histone deacetylase 3 Primary target of this compound Hs Inhibitor Inhibition >8.7 pIC50 - 2
pIC50 >8.7 (IC50 <2x10-9 M) [2]
histone deacetylase 6 Primary target of this compound Hs Inhibitor Inhibition >8.7 pIC50 - 2
pIC50 >8.7 (IC50 <2x10-9 M) [2]
histone deacetylase 10 Hs Inhibitor Inhibition 7.6 pIC50 - 2
pIC50 7.6 (IC50 2.82x10-8 M) [2]
histone deacetylase 1 Hs Inhibitor Inhibition 7.0 pIC50 - 2
pIC50 7.0 (IC50 1x10-7 M) [2]
histone deacetylase 2 Hs Inhibitor Inhibition 6.6 pIC50 - 2
pIC50 6.6 (IC50 2.38x10-7 M) [2]
histone deacetylase 8 Hs Inhibitor Inhibition 5.1 pIC50 - 2
pIC50 5.1 (IC50 8.104x10-6 M) [2]